Benzodiazepines: Effects on sleep

Sleep Disorders: Diagnosis and Therapeutics

Volumn , Issue , 2008, Pages 220-222

  Dikeos, Dimitris G ^a   Theleritis, Christos G ^a   Soldatos, Constantin R ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84914670735     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (38)

1. Soldatos CR, Kales A, Kales JD. Management of insomnia. Annual Rev Med 1979; 30: 301-12.
2. Soldatos CR. Insomnia. In Rakel R (ed.). Conn’s Current Therapy, 43rd edn. Philadelphia, Pennsylvania: WB Saunders, 1991: 29-31.
3. Dikeos DG, Soldatos CR. The pharmacotherapy of insomnia:efficacy and rebound with hypnotic drugs. Primary Care Companion J Clin Psychiatry 2002; 4(Suppl 1): 27-32.
4. Kales JD, Kales A, Bixler EO et al. Biopsychobehavioral correlates of insomnia, V: clinical characteristics and behavioral correlates. Am J Psychiatry 1984; 141: 1371-6.
5. Greenblatt DJ, Shader RI. Clinical pharmacokinetics of the benzodiazepines. In: Smith DE, Wesson DR (eds). The Benzodiazepines: Current Standards for Medical Practice. Lancaster, UK: MTP Press, 1985: 43-58.
6. Bailey L, Ward M, Musa MN. Clinical pharmacokinetics of benzodiazepines. J Clin Pharmacol 1994; 34: 804-11.
7. Soldatos CR, Kales A. Role of the sleep laboratory in the evaluation of hypnotic drugs. In: Priest RG, Pletscher A, Ward J (eds). Sleep Research (Proceedings of the North-European Symposium on Sleep Research, Basel, September 26-27, 1978). Lancaster, UK: MTP Press, 1979: 181-95.
8. Angst J, Borbély A, Engel R et al. The methodology of clinical trials with hypnotic drugs. Report of the sixth Consensus Conference. Pharmacopsychiatry 1995; 28: 2-7.
9. Bixler EO, Vgontzas AN, Kales A. Methodological issues in pharmacological studies of sleep. In: Kales A (ed). Handbook of Experimental Pharmacology: Pharmacology of Sleep. New York:Springer, 1995; 116: 322-43.
10. Schweitzer PK. Drugs that disturb sleep and wakefulness. In:Kryger MH, Roth T, Dement WC (eds). Principles and Practice of Sleep Medicine, 4th edn, Philadelphia, Pennsylvania: Elsevier Saunders, 2005: 499-518.
11. Paparrigopoulos TJ, Theleritis CG, Soldatos CR. Sleep and antidepressant medication. WPA Bulletin in Depression 2007; 11: 7-11.
12. Kales A, Vgontzas AN, Bixler EO. Hypnotic drugs. In: Kales A (ed.). Handbook of Experimental Pharmacology: Pharmacology of Sleep. New York: Springer, 1995; 116: 345-85.
13. Nowell PD, Mazumdar S, Buysse DJ et al. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997; 278: 2170-7.
14. Soldatos CR, Dikeos DG, Whitehead A. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 1999; 14:287-303.
15. Kales A, Bixler EO, Scharf MB et al. Sleep laboratory studies of flurazepam: a model for evaluating hypnotic drugs. Clin Pharmacol Ther 1976; 19: 576-83.
16. Roth TG, Roehrs TA, Koshorek GL et al. Hypnotic effects of low doses of quazepam in older insomniacs. J Clin Psychopharmacol 1997; 17: 401-6.
17. Kales A, Bixler EO, Soldatos CR et al. Quazepam and flurazepam:long-term use and extended withdrawal. Clin Pharmacol Ther 1982; 32: 781-8.
18. Mitler MM, Seidel WF, van den Hoed J et al. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study. J Clin Psychopharmacol 1984; 4: 2-13.
19. Adam KI, Adamason L, Brezinova V et al. Nitrazepam:lastingly effective but trouble on withdrawal. BMJ 1976; 1:1558-60.
20. Bixler EO, Kales A, Soldatos CR et al. Effectiveness of temazepam with short-, intermediate, and long-term use: sleep laboratory evaluation. J Clin Pharmacol 1978; 18: 110-18.
21. Rosekind MR, Seidel WF, Brown E et al. 28-night sleep laboratory evaluation of flunitrazepam. Sleep Res 1979; 8: 104.
22. Adam KI, Oswald I. Effects of lormetazepam and of flurazepam on sleep. Br J Clin Pharmacol 1984; 17: 531-8.
23. Lamphere J, Roehrs T, Zorick F et al. Chronic hypnotic efficacy of estazolam. Drugs Exp Clin Res 1986; 12: 687-91.
24. Monti J, Trenchi HM, Morales F et al. Flunitrazepam (Ro 5-4200) and sleep cycle in insomniac patients. Psychopharmacologia (Berl) 1974; 35: 371-9.
25. Scharf MB, Bixler EO, Kales A, Soldatos CR. Long-term sleep laboratory evaluation of flunitrazepam. Pharmacology 1979; 19: 173-81.
26. Kales A, Bixler EO, Soldatos CR et al. Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia. J Clin Pharmacol 1982; 22: 520-30.
27. Kales A, Bixler EO, Soldatos CR et al. Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal. Clin Pharmacol Ther 1986; 39: 345-52.
28. Kales A, Kales JD. Evaluation and Treatment of Insomnia. New York: Oxford University Press, 1984.
29. Kales A, Soldatos CR, Bixler EO et al. Rebound insomnia and rebound anxiety: a review. Pharmacology 1983; 26: 121-37.
30. Roehrs T, Vogel G, Roth T. Rebound insomnia: its determinants and significance. Am J Med 1990; 88(Suppl 3A): 39-42.
31. Bixler EO, Kales A, Brubaker BH, Kales JD. Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system. Pharmacology 1987; 35: 286-300.
32. Dikeos DG, Soldatos CR. The condition of insomnia: etiopathogenic considerations and their impact on treatment practices. Int Rev Psychiatry 2005; 17: 255-62.
33. Erman MK. Therapeutic options in the treatment of insomnia. J Clin Psychiatry 2005; 66(Suppl 9): 18-23.
34. Kales A, Soldatos CR, Bixler EO et al. Midazolam: dose- response studies of effectiveness and rebound insomnia. Pharmacology 1983; 26: 138-49.
35. Roehrs T, Zorick FJ, Sicklesteel JM et al. Effects of hypnotics on memory. J Clin Psychopharmacol 1983; 3: 310-13.
36. Scharf MB, Fletcher K, Graham JP. Comparative amnesic effects of benzodiazepine hypnotic agents. J Clin Psychiatry 1988; 49: 134-7.
37. Soldatos CR. Diagnosis and treatment of insomnia at the start of the 21st century. Primary Care Companion J Clin Psychiatry 2002; 4(Suppl 1): 3-7.
38. Soldatos CR, Dikeos DG. An integrative approach to the management of insomnia. Curr Opin Psychiatry 2003; 16(Suppl 2):93-9.